These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 29599087)
21. Genetic diversity of human respiratory syncytial virus isolated among children with acute respiratory infections in Southern Cameroon during three consecutive epidemic seasons, 2011-2013. Kenmoe S; Vernet MA; Miszczak F; Dina J; Schoenhals M; Beng VP; Vabret A; Njouom R Trop Med Health; 2018; 46():7. PubMed ID: 29618942 [TBL] [Abstract][Full Text] [Related]
22. Volume-Associated Clinical and Histopathological Effects of Intranasal Instillation in Syrian Hamsters: Considerations for Infection and Therapeutic Studies. Forero C; Ritter JM; Seixas JN; Coleman-McCray JD; Brake M; Condrey JA; Tansey C; Welch SR; Genzer SC; Spengler JR Pathogens; 2022 Aug; 11(8):. PubMed ID: 36015019 [TBL] [Abstract][Full Text] [Related]
23. Factors Limiting the Translatability of Rodent Model-Based Intranasal Vaccine Research to Humans. Cai L; Xu H; Cui Z AAPS PharmSciTech; 2022 Jul; 23(6):191. PubMed ID: 35819736 [TBL] [Abstract][Full Text] [Related]
24. Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Tai J; Han M; Lee D; Park IH; Lee SH; Kim TH Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631663 [TBL] [Abstract][Full Text] [Related]
25. Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs. Citron MP; McAnulty J; Callahan C; Knapp W; Fontenot J; Morales P; Flynn JA; Douglas CM; Espeseth AS Pathogens; 2021 Nov; 10(11):. PubMed ID: 34832599 [TBL] [Abstract][Full Text] [Related]
26. Coexpression of respiratory syncytial virus (RSV) fusion (F) protein and attachment glycoprotein (G) in a vesicular stomatitis virus (VSV) vector system provides synergistic effects against RSV infection in a cotton rat model. Brakel KA; Binjawadagi B; French-Kim K; Watts M; Harder O; Ma Y; Li J; Niewiesk S Vaccine; 2021 Nov; 39(47):6817-6828. PubMed ID: 34702618 [TBL] [Abstract][Full Text] [Related]
27. A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults. Aliprantis AO; Shaw CA; Griffin P; Farinola N; Railkar RA; Cao X; Liu W; Sachs JR; Swenson CJ; Lee H; Cox KS; Spellman DS; Winstead CJ; Smolenov I; Lai E; Zaks T; Espeseth AS; Panther L Hum Vaccin Immunother; 2021 May; 17(5):1248-1261. PubMed ID: 33121346 [TBL] [Abstract][Full Text] [Related]
28. Modified mRNA/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. Espeseth AS; Cejas PJ; Citron MP; Wang D; DiStefano DJ; Callahan C; Donnell GO; Galli JD; Swoyer R; Touch S; Wen Z; Antonello J; Zhang L; Flynn JA; Cox KS; Freed DC; Vora KA; Bahl K; Latham AH; Smith JS; Gindy ME; Ciaramella G; Hazuda D; Shaw CA; Bett AJ NPJ Vaccines; 2020; 5(1):16. PubMed ID: 32128257 [TBL] [Abstract][Full Text] [Related]
29. Vaccine containing G protein fragment and recombinant baculovirus expressing M2 protein induces protective immunity to respiratory syncytial virus. Jo YM; Kim J; Chang J Clin Exp Vaccine Res; 2019 Jan; 8(1):43-53. PubMed ID: 30775350 [TBL] [Abstract][Full Text] [Related]
30. Comparative models for human nasal infections and immunity. Casadei E; Salinas I Dev Comp Immunol; 2019 Mar; 92():212-222. PubMed ID: 30513304 [TBL] [Abstract][Full Text] [Related]
31. Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus. Boukhvalova MS; Yim KC; Blanco J Antivir Chem Chemother; 2018; 26():2040206618770518. PubMed ID: 29768937 [TBL] [Abstract][Full Text] [Related]